Coloplast A/S Revises 2030 Financial Ambitions and Provides Long-Term Guidance
Coloplast A/S has updated its long-term financial targets leading up to 2030, lowering its annual organic growth expectations to a range of 5-7%, down from the previous guidance of 7-8%. Despite this adjustment in growth rates, the company aims to strengthen its balance sheet, targeting a net debt/EBITDA ratio of below 2.0x by fiscal year 2029/30. For the FY 2026/27 period, Coloplast projects organic revenue growth between 5-7%, with reported revenue in DKK expected to grow by 7-9%. The company continues to maintain its outlook for the current fiscal year while providing investors with a clearer roadmap of its adjusted strategic trajectory and capital structure goals.
Tickers: $CLPBY
Topics: debt ratio financial outlook organic growth revenue guidance